111 (NASDAQ:YI) Director Jun Justin Luo Sells 70,440 Shares

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jun Justin Luo sold 70,440 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $0.25, for a total value of $17,610.00. Following the completion of the transaction, the director owned 710,551 shares of the company’s stock, valued at $177,637.75. The trade was a 9.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jun Justin Luo also recently made the following trade(s):

• On Tuesday, May 26th, Jun Justin Luo sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total value of $7,905.60.

111 Price Performance

Shares of NASDAQ YI opened at $5.26 on Friday. The stock has a market capitalization of $46.21 million, a price-to-earnings ratio of -5.26 and a beta of 0.66. The business has a 50-day moving average of $6.26 and a 200-day moving average of $5.58. 111, Inc. Sponsored ADR has a fifty-two week low of $2.48 and a fifty-two week high of $11.17.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded 111 from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, May 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, 111 has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.